Available online 29 November 2023

Author links open overlay panelHiba Boussaa a b, Saffet Nouicer a b, Saoussen Miladi a b, Yesmine Makhlouf a b, Kawther Ben Abdelghani a b, Alia Fazaa a b, Ahmed Laater a bShow more

Recommended articles

*

The case has been declared to the National Center of Pharmacovigilance Chalbi Belkahia of Tunis (Tunisia) on 11 June 2022 under the number 1684/22.

View full text

© 2023 Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.

Recommended articlesArticle Metrics